GSK, Belgium
GSK (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)
OP-26A - Evaluation of the Potential Confounding Effect of Shingles on the Risk of Guillain-barré Syndrome After Vaccination with the Recombinant Zoster Vaccine
Monday, August 23, 20211:45 PM – 3:30 PM US Eastern Time